Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 :

Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office). - 1 online resource (59 pages). - Report / 116th Congress, 1st session, House of Representatives ; 116-46 . - United States. Congress. House. Report ; 116-46. .

"May 2, 2019." CRDP Program record.

Includes bibliographical references.


Pharmaceutical industry--Quality control.--United States
Generic drugs--Standards--United States.
Generic drugs--Effectiveness--United States.
Generic drugs--Prices.
Drugs--Cost effectiveness.--United States


Legislative materials.

KF32 / .E55 2019g

1008-I (online)

Y 1.1/8:116-46
logopucpr-y-vive

Contáctanos

¡Queremos saber de ti!

Tel. 787.841.2000 Ext. 1801

bibliotecavaldes@pucpr.edu

⁣Búscanos en las redes

© 2026 Desarrollado por Ignite Online • All Rights Reserved • Powered by Koha.